Evidence map›Paper›PMID 38327091›Full record

ArticleMolecular oncology2024

Global pannexin 1 deletion increases tumor-infiltrating lymphocytes in the BRAF/Pten mouse melanoma model.

Rafael E Sanchez-Pupo, Garth A Finch, Danielle E Johnston, Heather Craig, Rober Abdo, Kevin Barr, Steven Kerfoot, Lina Dagnino, Silvia Penuela

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Rafael E Sanchez-PupoDepartment of Anatomy and Cell Biology, Western University, London, Canada.ORCID 0000-0002-6970-2137
Garth A FinchDepartment of Anatomy and Cell Biology, Western University, London, Canada.
Danielle E JohnstonDepartment of Anatomy and Cell Biology, Western University, London, Canada.
Heather CraigDepartment of Microbiology and Immunology, Western University, London, Canada.
Rober AbdoDepartment of Anatomy and Cell Biology, Western University, London, Canada.
Kevin BarrDepartment of Anatomy and Cell Biology, Western University, London, Canada.
Steven KerfootDepartment of Microbiology and Immunology, Western University, London, Canada.
Lina DagninoDepartment of Physiology and Pharmacology, Western University, London, Canada.
Silvia PenuelaDepartment of Anatomy and Cell Biology, Western University, London, Canada.ORCID 0000-0003-4829-5517
Western University · CA

Funding

CIHR FRN 153112
6 · The paper itself

Abstract

Immunotherapies for malignant melanoma seek to boost the anti-tumoral response of CD8

Indexed as

MelanomaSkin NeoplasmsAnimalsCD8-Positive T-LymphocytesConnexinsLymphocytes, Tumor-InfiltratingMiceNerve Tissue ProteinsProto-Oncogene Proteins B-rafTumor MicroenvironmentConnexinsNerve Tissue ProteinsPanx1 protein, mouseProto-Oncogene Proteins B-rafimmune infiltrationmelanomapannexin 1T cell

Identifiers

PMID38327091
PMCPMC10994229
OpenAlexW4391649897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.